New Research Award in Sarcoidosis Funded by Mallinckrodt Pharmaceuticals Inc.June 6, 2017 at 8:59 am
The new ATS Foundation/Mallinckrodt Pharmaceuticals Inc. Research Fellowship in Sarcoidosis will award $40,000 per year for two years to one investigator conducting research in the area of sarcoidosis.
Sarcoidosis is an inflammatory disorder involving multiple organs, and the causes and pathogenesis are unknown. Research offers patients and their families hope. According to Sarcoidosis Patient-Advocate Trina Massey Davis, “Sarcoidosis may be a ‘snowflake disease,’ but living with it hits like an avalanche. We need your help to dig us out.”
The fellowship application process is now open. The two-year funding period is December 2017 through November 2019. Applications will be reviewed for their scientific merit, innovation, feasibility, and relevance to sarcoidosis.
Learn more about the ATS Foundation/Mallinckrodt Pharmaceuticals Inc. Research Fellowship, and additional fellowship opportunities on our website.
Since 2004, the ATS Foundation Research Program has awarded $16,190,000 to 210 investigators who have gone on to secure $214,706,677 in federal funding as principal investigators.